AILNP

Serial Number 97636213
Registration 7755187
700

Registration Progress

Application Filed
Oct 18, 2022
Under Examination
Dec 19, 2023
Approved for Publication
Oct 24, 2023
Published for Opposition
Oct 24, 2023
Registered
Apr 8, 2025

Trademark Image

AILNP

Basic Information

Serial Number
97636213
Registration Number
7755187
Filing Date
October 18, 2022
Registration Date
April 8, 2025
Published for Opposition
October 24, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 8, 2025
Registration
Registered
Classes
042

Rights Holder

HANGZHOU JITAI PHARMACEUTICAL TECHNOLOGY CO.,LTD

16
Address
Room 116, 1st Floor, Building 2, No. 658
Bin'an Road, Binjiang District, Hangzhou
Zhejiang Province N/A
CN

Ownership History

HANGZHOU JITAI PHARMACEUTICAL TECHNOLOGY CO.,LTD

Original Applicant
16
Zhejiang Province CN

BEIJING JITAI PHARMACEUTICAL TECHNOLOGY CO.,LTD

Original Applicant
16
Haidian Dist, Beijing CN

HANGZHOU JITAI PHARMACEUTICAL TECHNOLOGY CO.,LTD

Owner at Publication
16
Zhejiang Province CN

BEIJING JITAI PHARMACEUTICAL TECHNOLOGY CO.,LTD

Owner at Publication
16
Haidian Dist, Beijing CN

HANGZHOU JITAI PHARMACEUTICAL TECHNOLOGY CO.,LTD

Original Registrant
16
Zhejiang Province CN

BEIJING JITAI PHARMACEUTICAL TECHNOLOGY CO.,LTD

Original Registrant
16
Haidian Dist, Beijing CN

Legal Representation

Attorney
Mark E. Bandy

USPTO Deadlines

Next Deadline
1980 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-04-08)
Due Date
April 08, 2031
Grace Period Ends
October 08, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Apr 8, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 8, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 17, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Mar 17, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jan 11, 2025 ALIE A ASSIGNED TO LIE Loading...
Jan 10, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 10, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 6, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 10, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 10, 2024 GNRT O NON-FINAL ACTION E-MAILED Loading...
Sep 10, 2024 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Aug 3, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 3, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jun 17, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 17, 2024 IUAF S USE AMENDMENT FILED Loading...
Dec 19, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 24, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 24, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 4, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 20, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 18, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 28, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 28, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 28, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 17, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 17, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 17, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 2, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 1, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 21, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Design of computer databases; conversion of computer programs and data, other than physical conversion; digitization of documents being scanning; computer programming in medical care; providing virtual computer systems through cloud computing; pharmaceutical drug development; drug evaluation in the nature of evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous and illegal materials; pharmaceutical research; scientific research and development; conducting early evaluation of new drug fields in the nature of evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous and illegal materials; computer hardware design; research and development of new products for others; providing computer software design for others; electronic data storage; conducting technical project studies in the nature of technical research in the field of pharmaceutical studies; conversion of data or documents from physical to electronic media; clinical trials, namely, scientific research in the nature of conducting clinical trials for others; animal genetics research in the nature of studying the mechanism of action of compound combinations in animals; computer programming
First Use Anywhere: Oct 22, 2022
First Use in Commerce: Oct 22, 2022

Classification

International Classes
042